Detalles de la búsqueda
1.
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.
Ann Intern Med
; 177(2): 155-164, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38252942
2.
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.
Blood
; 137(4): 556-568, 2021 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33104215
3.
Child and family perceptions of satisfaction with neutropenia management in pediatric acute myeloid leukemia.
Pediatr Blood Cancer
; 70(8): e30420, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37194639
4.
Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation Rescues Marrow Failure From Acute Leukemia Therapy in a Patient With Previously Undiagnosed Ligase IV Syndrome.
J Pediatr Hematol Oncol
; 45(1): e139-e141, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35665709
5.
Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.
Biol Blood Marrow Transplant
; 26(2): 333-342, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31563573
6.
The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.
Biol Blood Marrow Transplant
; 26(9): 1747-1756, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32464284
7.
Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemia.
Pediatr Blood Cancer
; 65(4)2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29286570
8.
Timing and Utility of Relapse Surveillance after Allogeneic Hematopoietic Cell Transplantation in Children with Leukemia.
Biol Blood Marrow Transplant
; 23(4): 696-700, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28063963
9.
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(4): 552-561, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28065838
10.
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.
Haematologica
; 102(11): 1823-1832, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28818869
11.
Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(9): 1646-1653, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27252110
12.
Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.
Br J Haematol
; 174(4): 515-25, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27255787
13.
Imaging findings in a child with calcineurin inhibitor-induced pain syndrome after bone marrow transplant for beta thalassemia major.
Pediatr Radiol
; 46(11): 1618-21, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27324395
14.
Allogeneic Hematopoietic Cell Transplantation for Children with Sickle Cell Disease Is Beneficial and Cost-Effective: A Single-Center Analysis.
Biol Blood Marrow Transplant
; 21(7): 1258-65, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25615608
15.
Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 62(10): 1775-81, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25946708
16.
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research.
Cancer Med
; 13(7): e6966, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572962
17.
Trends in Volumes and Survival After Hematopoietic Cell Transplantation in Racial/Ethnic Minorities.
Blood Adv
; 2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38661372
18.
Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?
Transplant Cell Ther
; 29(8): 531.e1-531.e4, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37169288
19.
Identifying and Validating Pediatric Hospitalizations for MIS-C Through Administrative Data.
Pediatrics
; 151(5)2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37102310
20.
Epidemiology and Severity of Illness of MIS-C and Kawasaki Disease During the COVID-19 Pandemic.
Pediatrics
; 152(5)2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37791428